Von Hippel Lindau (VHL) is a rare genetic cancer syndrome, an alteration in the VHL-tumor-suppressor gene, which puts the individual at increased risk of developing tumors in various organs throughout life.
Educating and Empowering People by VHL Family Alliance published 4 months ago
An empowering message full of suggestions for activities.
I just returned from the 9th International Medical Symposium on von Hippel-Lindau, this year held in Rio de Janeiro, Brazil, hosted by the Brazilian National Cancer Institute (INCA) and chaired by Dr. Jose Claudio Casali da Rocha, head of the Brazilian National Tumor Bank, and co-chaired by Dr. Eric Jonasch, Genito-Urinary Oncologi...
My personal pathway, my strength ... by lolea9 published 6 months ago
LIVING WITH VHL (Von Hippel-Lindau) VHL is an autosomal dominant gene, a tumor suppressor. In the general population, this gene does its job and makes a protein that suppresses the development of any tumors as they arise. In my case, this gene is defective. Thus, damage of any kind arises at different rates and in different organs. VHL affects mainly the following areas: pancreas, kidney, cereb...
2011 Projects of the Spanish VHL Family Alliance by Karina published 8 months ago
Hello,
This message is especially for Gerhard and other colleagues from other associations. I had had the idea of writing it after receiving a message from Gerhard where he requested basic information about the Spanish VHL Association.
It was 3 years ago when we decided to initiate a project called "Every health center should have the VHL Manual". We applied for a subsidy from th...
VHLFA Annual Meeting and Conference 2011 by VHL Family Alliance published 8 months ago
From VHL Family Alliance Director Joyce Graff:
"The Houston meeting was wonderful! Some 70 people met at the M.D. Anderson Cancer Center to hear 8 outstanding speakers and exchange storie...